SharpMed, LLC is proud to announce a major milestone: the Turbo® O₂ Cap has received its fourth issued patent. This latest addition strengthens our growing intellectual property portfolio and reinforces our commitment to innovation in airway management.
The Turbo® O₂ Cap is a simple yet groundbreaking device designed to attach seamlessly to any standard endotracheal tube. Developed to enhance oxygen delivery during difficult intubations, the Turbo® O₂ Cap represents a new frontier in respiratory support and patient safety.
“This patent is key to our strategy of becoming the future market leader in devices that support safer intubations and improve outcomes. We believe the Turbo® O₂ Cap may become the new standard of care.” – Chris Salvino, MD, CEO, SharpMed, LLC
As we continue to move forward with commercialization, we remain dedicated to developing accessible, life-saving tools that make a measurable impact in clinical practice.